[unable to retrieve full-text content]

Employees work on paracetamol production line for UPSA brand of Bristol-Myers Squibb Group at the company’s factory in Le Passage, near Agen, France March 29, 2018. REUTERS/Regis Duvignau (Reuters) – Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd (4581.T) is said to be close to a $1.6 billion deal for Bristol-Myers Squibb Co’s (BMY.N) French […]